Oaktree Acquisition Corp. III Life Sciences Reports Q2 2026 Financial Results in SEC 10-Q Filing
Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) has filed its Q2 2026 financial results with the SEC, reporting a net income of $1,604,621 for the quarter ended June 30, 2026. This figure is a decrease from $1,874,343 in Q2 2025. The company's Trust Account …